Unraveling tumor microenvironment of small-cell lung cancer: Implications for immunotherapy
- 29 September 2022
- journal article
- research article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 86 (Pt 2) , 117-125
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients’ bedJournal of Translational Medicine, 2013
- VEGFA/VEGFR2-targeted therapies prevent the VEGFA-induced proliferation of regulatory T cells in cancerOncoImmunology, 2013
- Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T LymphocytesCancer Research, 2012
- Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodelingFrontiers in Physiology, 2012
- HIF-1α effects on angiogenic potential in human small cell lung carcinomaJournal of Experimental & Clinical Cancer Research, 2011
- Paclitaxel Plus Bevacizumab in Patients with Chemosensitive Relapsed Small Cell Lung Cancer: A Safety, Feasibility, and Efficacy Study from the Hoosier Oncology GroupJournal of Thoracic Oncology, 2010
- Treatment with HIF-1α Antagonist PX-478 Inhibits Progression and Spread of Orthotopic Human Small Cell Lung Cancer and Lung Adenocarcinoma in MiceJournal of Thoracic Oncology, 2010
- Bicarbonate Increases Tumor pH and Inhibits Spontaneous MetastasesCancer Research, 2009
- The impact of O2 availability on human cancerNature Reviews Cancer, 2008
- Critical Role for Mitochondrial Oxidative Phosphorylation in the Activation of Tumor Suppressors Bax and BakJNCI: Journal of the National Cancer Institute, 2006